The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Mirena (levonorgestrel-releasing intrauterine system), extending the duration of use for up to 8 ...

"Bayer is pleased with the plaintiff's decision to voluntarily dismiss these meritless claims against the Company in Sidhu and believes that the replicated claims raised in the Copeland filing are ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that ...

The key differences between Kyleena and Mirena are size, duration, and their affect on heavy periods. A healthcare professional can help you weigh your options and determine which one is right for you ...

A Dec. 19 Health section article incorrectly described Depo-Provera as containing "higher levels of the same hormone" as the new intrauterine device Mirena. Depo-Provera is a progestin-only ...

(RTTNews) - German pharmaceutical company Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Friday that Mirena (52mg LNG IUS), its long-acting reversible intrauterine system, received regulatory approval ...